4//SEC Filing
Higgons John Duncan 4
Accession 0001640455-22-000070
CIK 0001640455other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 9:03 PM ET
Size
10.0 KB
Accession
0001640455-22-000070
Insider Transaction Report
Form 4
Higgons John Duncan
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-24+20,000→ 20,000 totalExercise: $2.80Exp: 2032-06-24→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option will vest in equal quarterly installments during the four quarters following the grant date, provided that if the Issuer's 2023 annual meeting of stockholders occurs before the one-year anniversary of the grant date, the unvested portion of the option will vest as of the date of such annual meeting, subject in each case to the Reporting Person's continued service on the Issuer's board of directors.
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001581954
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 9:03 PM ET
- Size
- 10.0 KB